Literature DB >> 12684599

Prevention of heart failure: effective strategies to combat the growing epidemic.

Gregg C Fonarow1, Tamara B Horwich.   

Abstract

In light of the increasing prevalence, morbidity, and mortality of heart failure, effective preventative strategies are urgently needed. Risk factors for heart failure include coronary artery disease and other atherosclerotic vascular diseases, hypertension, diabetes, renal insufficiency, obesity, and family history of cardiomyopathy. Essential strategies for prevention of heart failure are modification of risk factors for heart failure development; comprehensive hypertension, atherosclerosis, and diabetes treatment; and detection and treatment of asymptomatic left ventricular dysfunction. The B-type natriuretic peptide assay may aid in identifying asymptomatic left ventricular dysfunction in patients with risk factors for heart failure. In patients with hypertension, atherosclerosis, and/or diabetes, angiotensin-converting enzyme inhibitor, beta-blocker, aspirin, and statin therapy can prevent progression to symptomatic heart failure. Avoidance of calcium channel-blockers as first-line antihypertensive therapy can also reduce the risk of heart failure. There remain substantial opportunities to improve implementation of therapies proven to prevent heart failure in the large number of patients at risk.

Entities:  

Mesh:

Year:  2003        PMID: 12684599

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  3 in total

Review 1.  Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?

Authors:  Kirkwood F Adams
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

2.  A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis.

Authors:  Lutz Hamann; Abuzeid Gomma; Nicolas W J Schröder; Cordula Stamme; Christiane Glaeser; Susanne Schulz; Michael Gross; Stefan D Anker; Kim Fox; Ralf R Schumann
Journal:  J Mol Med (Berl)       Date:  2005-05-04       Impact factor: 4.599

Review 3.  Is heart failure different on the two continents (North America and Europe)?

Authors:  Rachel Hughes-Doichev; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.